Related references
Note: Only part of the references are listed.Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
Nicholas G. Minutolo et al.
FRONTIERS IN ONCOLOGY (2019)
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
Eytan Herzig et al.
CELL (2019)
CAR T cell therapy for B-cell lymphomas
Julio C. Chavez et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
A. J. Davenport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
Sophie Viaud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
Alec J. Walker et al.
MOLECULAR THERAPY (2017)
A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo et al.
SCIENCE SIGNALING (2017)
A disease-linked ULBP6 polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding
Jianmin Zuo et al.
SCIENCE SIGNALING (2017)
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
Kevin A. Hay et al.
DRUGS (2017)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors
Hiroki Torikai et al.
MOLECULAR THERAPY (2016)
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
Reza Ghasemi et al.
NATURE COMMUNICATIONS (2016)
IL-18 Secreting CAR T Cells Enhance Cell Persistence, Induce Prolonged B Cell Aplasia and Eradicate CD19+Tumor Cells without Need for Prior Conditioning
Mauro P. Avanzi et al.
BLOOD (2016)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
Brian Philip et al.
BLOOD (2014)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Victor D. Fedorov et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo
Evripidis Lanitis et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
Aaron M. Ring et al.
NATURE IMMUNOLOGY (2012)
Human NKG23-ligands: cell biology strategies to ensure immune recognition
Lola Fernandez-Messina et al.
FRONTIERS IN IMMUNOLOGY (2012)
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
Xiuli Wang et al.
BLOOD (2011)
Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions
David J. Culpepper et al.
MOLECULAR IMMUNOLOGY (2011)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
Gregory L. Moore et al.
MABS (2010)
Structure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D Ligands
Steffen Mueller et al.
PLOS PATHOGENS (2010)
Regulation of NKG2D ligands: a purposeful but delicate affair
Thomas Spies
NATURE IMMUNOLOGY (2008)
Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries
Raffi Tonikian et al.
NATURE PROTOCOLS (2007)
Identification of an interleukin-15α receptor-binding site on human interleukin-15
J Bernard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: Not induced fit but rigid adaptation
BJ McFarland et al.
IMMUNITY (2003)
Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3
S Radaev et al.
IMMUNITY (2001)
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA
PW Li et al.
NATURE IMMUNOLOGY (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Engineered antibodies with increased activity to recruit complement
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
